BI

BioPlus Acquisition CorpNASDAQ BIOS Stock Report

Last reporting period 30 Jun, 2023

Updated —

Last price

Market cap $B

0.209

Micro

Exchange

XNAS - Nasdaq

BIOS Stock Analysis

BI

Uncovered

BioPlus Acquisition Corp is uncovered by Eyestock quantitative analysis.

Market cap $B

0.209

Dividend yield

Shares outstanding

29.31 B

BioPlus Acquisition Corp. is an early stage blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in New York City, New York and currently employs 2 full-time employees. The company went IPO on 2021-12-03. The firm is formed for the purpose effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The firm has not selected any specific business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target. The firm intends to focus its search on companies in the life sciences industry. The firm has not commenced any operations nor generated any revenue.

View Section: Eyestock Rating